Bio-Techne (TECH) Protective Put Calculator

Calculator · free · no signup · TECH

Price a protective put, zero-cost collar, or put spread on Bio-Techne. Annual cost, max loss, upside cap, tax treatment, auto-filled from current TECH option chain.

AlphaLatitude Inc. · Free ToolsOur tools respect your browsing privacy. Independently verified:Blacklight, August 2026 scan: zero trackersWebbkoll, August 2026 scan: no cookiesMDN HTTP Observatory grade, scanned live

You priced one hedge. The beta picks the right hedge structure given your full equity stack and tax situation.

Request beta access →

Related calculators: Stock Concentration Calculator

About Bio-Techne

Bio-Techne (TECH) is a public Life Sciences company, incorporated in Minnesota and headquartered in Minneapolis, MN.

Last close: $72.4 per share (as of 2026-10-02).

Equity grants at Bio-Techne typically include restricted stock units (RSUs).

Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

Source: Wikipedia (CC BY-SA 4.0)

Bio-Techne traces to 1976, when Roger Lucas founded Research and Diagnostic Systems (R&D Systems) in Minneapolis to sell blood-control samples for hematology labs; the company later renamed itself Bio-Techne and expanded into cytokines, antibodies, and RNAscope in situ hybridization reagents used by biotech researchers to visualize gene activity in tissue. It reported net sales above $1.2 billion for fiscal 2025 and employs roughly 2,900 people. On June 25, 2026, Germany's Merck KGaA agreed to acquire the company for $73 per share in cash, a deal valuing Bio-Techne's equity and debt combined (enterprise value) at about $11.3 billion.

Sources: investors.bio-techne.com · prnewswire.com · gurufocus.com · en.wikipedia.org

Equity comp at Bio-Techne

  • RSUs use single-trigger vesting: shares become yours as each portion vests on schedule, and the value is taxed as ordinary income at that point. No IPO or acquisition is required.

Researched 2026-08-17.

OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Bio-Techne.

A protective put caps your downside on the TECH position at a chosen floor; a zero-cost collar pays for that floor by capping the upside. This calculator prices both structures off the current TECH option chain, with annual cost, max loss, and tax-treatment notes.

Example: a 5,000-share TECH position at $72.4 is worth $362,000. A 1-year 30%-OTM put on that position typically runs 2-4% of position value per year (about $7,240 to $14,480) before any premium offset from a short call. The calculator prices both structures off TECH's current option chain so you see the actual cost for your chosen floor, tenor, and cap.

All Bio-Techne tools → · Use the generic Protect Your Stock Calculator for any company.

Bio-Techne equity questions

How much does it cost to hedge TECH stock?
The cost of a protective put depends on how far below the current price you set the floor, how long the protection lasts, and TECH's option-implied volatility. A zero-cost collar lowers that cost by selling away some upside. The calculator above prices both structures off the current TECH option chain and shows the annual cost, maximum loss, and tax treatment.
Does Bio-Techne grant ISOs, NSOs, or RSUs?
Equity compensation at Bio-Techne typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
Do Bio-Techne RSUs use double-trigger vesting?
No. Bio-Techne restricted stock units (RSUs) use single-trigger vesting: each tranche becomes yours as it vests on schedule, taxed as ordinary income at that point, with no liquidity event required.
Find another companyLife Sciences Tools peers

One piece of the puzzle.

OptionsAhoy plans your Bio-Techne equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.

Request beta access